182 results
8-K
EX-99.1
NVOS
Novo Integrated Sciences Inc
31 May 24
Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program
9:00am
. This acceleration of “ease-of-access” in the patient/practitioner interaction for non-critical care diagnosis and subsequent treatment minimizes
8-K
EX-99.1
NVOS
Novo Integrated Sciences Inc
30 May 24
Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program
4:30pm
to primary medical centers with mass-services. This acceleration of “ease-of-access” in the patient/practitioner interaction for non-critical care
8-K
EX-99.1
NVOS
Novo Integrated Sciences Inc
15 Apr 24
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
4:30pm
-services. This acceleration of “ease-of-access” in the patient/practitioner interaction for non-critical care diagnosis and subsequent treatment minimizes
8-K
EX-99.1
NVOS
Novo Integrated Sciences Inc
11 Apr 24
Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement
5:00pm
and away from on-site visits to primary medical centers with mass-services. This acceleration of “ease-of-access” in the patient/practitioner interaction
8-K
EX-10.3
v5rxuvp0qo922y09
11 Apr 24
Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement
5:00pm
8-K
EX-99.1
mln6spzo
26 Mar 24
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
2:30pm
8-K
EX-99.1
bdvabnfd6oia2 gc7o7g
21 Feb 24
Regulation FD Disclosure
4:05pm
8-K
EX-99.1
vt3b3
20 Feb 24
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note
2:00pm
8-K
EX-99.1
ao6 wslsg4
16 Feb 24
Novo Integrated Sciences Appoints New President
2:00pm
8-K
EX-99.1
u0467yw
22 Jan 24
Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results
4:30pm
8-K
EX-99.1
et0 gntl85fblvio
19 Dec 23
Regulation FD Disclosure
4:45pm
8-K
EX-99.1
3iknfaor
14 Dec 23
Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results
5:00pm
8-K
EX-99.1
5xji5a9
5 Dec 23
Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India
1:20pm
8-K
EX-99.1
dqryuv g8sm
4 Dec 23
Novo Integrated Sciences’ Purchase and Sale Agreement to Acquire Ophir Collection Receives Court Approval
11:30am
8-K
EX-99.1
6pbse
24 Nov 23
Regulation FD Disclosure
9:20am
8-K
EX-99.1
ynwyhvg
6 Nov 23
Novo Integrated Sciences Announces Reverse Stock Split
11:59am
8-K
EX-99.1
1ll 0o7pq
6 Nov 23
Novo Integrated Sciences Advised Receipt of Proceeds of RC Consulting Promissory Note Expected in 3-5 Business Days
6:04am